Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

Author:

De Oliveira David M. P.1,Forde Brian M.2ORCID,Phan Minh-Duy1ORCID,Steiner Bernhard1,Zhang Bing3,Zuegg Johannes3,El-deeb Ibrahim M.4,Li Gen1,Keller Nadia1,Brouwer Stephan1,Harbison-Price Nichaela1,Cork Amanda J.1,Bauer Michelle J.2,Alquethamy Saleh F.5,Beatson Scott A.1ORCID,Roberts Jason A.267ORCID,Paterson David L.2,McEwan Alastair G.1,Blaskovich Mark A. T.3,Schembri Mark A.1ORCID,McDevitt Christopher A.5ORCID,von Itzstein Mark4ORCID,Walker Mark J.1

Affiliation:

1. The University of Queensland, School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia

2. The University of Queensland, UQ Centre for Clinical Research, Australian Infectious Diseases Research Centre, Brisbane, QLD, Australia

3. The University of Queensland, Centre for Superbug Solutions, Institute for Molecular Bioscience, Brisbane, QLD, Australia

4. Griffith University, Institute for Glycomics, Gold Coast, QLD, Australia

5. The University of Melbourne, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia

6. Royal Brisbane and Women’s Hospital, Departments of Pharmacy and Intensive Care Medicine, Brisbane, QLD, Australia

7. University of Montpellier, Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, Nîmes, France

Abstract

Within intensive care unit settings, multidrug-resistant (MDR) Acinetobacter baumannii is a major cause of ventilator-associated pneumonia, and hospital-associated outbreaks are becoming increasingly widespread. Antibiotic treatment of A. baumannii infection is often compromised by MDR strains resistant to last-resort β-lactam (e.g., carbapenems), polymyxin, and tetracycline class antibiotics.

Funder

Department of Health | National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3